HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Jeffrey Medeiros Selected Research

Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

4/2024Diagnostic utility of immunohistochemistry in detection of NPM1 mutations in acute myeloid leukemia with a patchy distribution.
1/2023Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
1/2022TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia.
1/2022PPP1R7 Is a Novel Translocation Partner of CBFB via t(2;16)(q37;q22) in Acute Myeloid Leukemia.
1/2021Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities.
1/2021Incidental identification of inv(16)(p13.1q22)/CBFB-MYH11 variant transcript in a patient with therapy-related acute myeloid leukemia by routine leukemia translocation panel screen: implications for diagnosis and therapy.
12/2020Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
12/2020Clonal evolution with acquisition of BCR-ABL1 in refractory acute myeloid leukemia post therapy with FLT3-inhibitor.
10/2020High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia.
10/2020Leukemic phase of Richter transformation: A mimic of acute myeloid leukemia that responded to Ibrutinib monotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


L Jeffrey Medeiros Research Topics

Disease

196Neoplasms (Cancer)
03/2024 - 02/2002
96Lymphoma (Lymphomas)
12/2023 - 02/2002
67Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
03/2024 - 05/2002
54Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024 - 06/2002
51Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 02/2004
41Hodgkin Disease (Hodgkin's Disease)
07/2023 - 02/2002
38Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2024 - 05/2002
35B-Cell Lymphoma (Lymphoma, B Cell)
01/2024 - 11/2002
29B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2023 - 05/2002
27Disease Progression
12/2023 - 01/2007
27Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2023 - 10/2007
23T-Cell Lymphoma (Lymphoma, T Cell)
02/2023 - 09/2002
18Leukemia
01/2024 - 02/2004
16Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2023 - 04/2002
16Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2022 - 11/2002
15Chromosome Aberrations (Chromosome Abnormalities)
11/2021 - 01/2007
15BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 05/2002
13Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022 - 11/2002
10Residual Neoplasm
04/2024 - 02/2002
10Multiple Myeloma
12/2023 - 09/2004
10Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2023 - 11/2002
10Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 12/2010
10Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 05/2002
8Waldenstrom Macroglobulinemia (Macroglobulinemia)
10/2017 - 11/2002
8Genetic Translocation (Chromosomal Translocation)
10/2015 - 04/2002
7Philadelphia Chromosome
01/2019 - 11/2010
7Acute Promyelocytic Leukemia
01/2015 - 03/2004
6Lymphadenopathy
03/2024 - 02/2002
6Primary Myelofibrosis (Myelosclerosis)
02/2022 - 07/2004
6Eosinophilia
01/2021 - 05/2003
6Carcinoma (Carcinomatosis)
01/2019 - 06/2005
6Carcinogenesis
07/2013 - 03/2006
5Burkitt Lymphoma (Burkitt's Lymphoma)
02/2023 - 11/2002
5Epstein-Barr Virus Infections
07/2022 - 08/2013
5Blast Crisis (Blast Phase)
01/2021 - 03/2011
5Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2019 - 10/2009
5Fibrosis (Cirrhosis)
01/2018 - 07/2004
4Paraproteinemias (Monoclonal Gammopathy)
12/2023 - 02/2005
4Castleman Disease (Castleman's Disease)
08/2023 - 06/2014
4Plasmacytoma
02/2023 - 11/2002
4Cytopenia
01/2020 - 03/2010

Drug/Important Bio-Agent (IBA)

51Proteins (Proteins, Gene)FDA Link
12/2023 - 02/2002
42Rituximab (Mabthera)FDA Link
12/2023 - 02/2002
37Anaplastic Lymphoma KinaseIBA
01/2021 - 09/2002
24Cyclin D1IBA
01/2024 - 05/2002
24Doxorubicin (Adriamycin)FDA LinkGeneric
12/2023 - 03/2002
20Biomarkers (Surrogate Marker)IBA
12/2023 - 12/2007
20Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2023 - 06/2008
18Vincristine (Oncovin)FDA LinkGeneric
12/2023 - 03/2002
17DNA (Deoxyribonucleic Acid)IBA
12/2020 - 08/2002
15Tyrosine Kinase InhibitorsIBA
12/2023 - 09/2011
15ParaffinIBA
12/2023 - 02/2002
14Prednisone (Sone)FDA LinkGeneric
12/2023 - 03/2002
14AntigensIBA
01/2022 - 02/2002
13Phosphotransferases (Kinase)IBA
12/2023 - 08/2004
13Messenger RNA (mRNA)IBA
11/2023 - 05/2002
12Formaldehyde (Formol)FDA Link
12/2023 - 09/2003
12RNA (Ribonucleic Acid)IBA
09/2023 - 04/2004
12Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
04/2013 - 04/2002
11Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 10/2005
10Cytarabine (Cytosar-U)FDA LinkGeneric
01/2020 - 10/2005
10AntibodiesIBA
10/2018 - 04/2004
10T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018 - 02/2002
9Capsules (Microcapsules)IBA
06/2023 - 07/2012
9CytokinesIBA
02/2023 - 11/2004
9Immunoglobulins (Immunoglobulin)IBA
01/2023 - 01/2011
9ParaproteinsIBA
12/2022 - 03/2002
9Immunoglobulin M (IgM)IBA
08/2019 - 08/2003
8L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2023 - 02/2009
8Peroxidase (Myeloperoxidase)IBA
11/2022 - 08/2005
8Imatinib Mesylate (Gleevec)FDA Link
01/2020 - 07/2004
7NucleophosminIBA
04/2024 - 07/2006
7NF-kappa B (NF-kB)IBA
11/2023 - 02/2004
7Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 02/2002
7Pyridinolcarbamate (P23)IBA
11/2014 - 05/2002
6Immunoglobulin G (IgG)IBA
01/2023 - 05/2016
6LigandsIBA
07/2022 - 01/2006
6RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2021 - 03/2007
6Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
01/2021 - 09/2015
6MicroRNAs (MicroRNA)IBA
06/2015 - 07/2011
6fludarabineIBA
06/2012 - 02/2002
5ibrutinibIBA
10/2022 - 01/2016
5Etoposide (VP 16)FDA LinkGeneric
01/2020 - 05/2015
5Granzymes (Granzyme)IBA
04/2019 - 11/2012
5Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2018 - 01/2011
5NucleotidesIBA
01/2017 - 02/2012
5TOR Serine-Threonine KinasesIBA
12/2010 - 07/2006
4Immune Checkpoint InhibitorsIBA
06/2023 - 01/2016
4Reticulin (Reticular Fiber)IBA
01/2018 - 07/2004
4Transcription Factors (Transcription Factor)IBA
10/2017 - 06/2005

Therapy/Procedure

160Therapeutics
04/2024 - 05/2002
52Drug Therapy (Chemotherapy)
12/2023 - 02/2002
24Breast Implants (Breast Implant)
03/2024 - 09/2009
19Radiotherapy
01/2021 - 03/2002
17Stem Cell Transplantation
01/2023 - 10/2006
6Immunotherapy
01/2024 - 01/2018
6Splenectomy
01/2017 - 04/2006
5Aftercare (After-Treatment)
01/2020 - 01/2004
4Hematopoietic Stem Cell Transplantation
02/2022 - 08/2014
4Induction Chemotherapy
10/2018 - 05/2003